Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
sicklecellanemianews
13h
Pfizer withdraws Oxbryta from global markets, cites safety concerns
Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Walz-Vance VP debate
Iran launches missile attack
Helene wreaks havoc
Sworn in as Mexico's pres
'Good Times' star dies
Pledges support for Ukraine
Files for bankruptcy
120 new assault allegations
FL homeless law kicks in
CA sues Catholic hospital
US warns foreign operators
Broadway star dies at 70
Settlement checks delayed
Jimmy Carter turns 100
Explosive devices found
'Pled guilty to journalism'
Asylum restrictions extended
Kentucky sheriff steps down
Arkansas sues YouTube
Gonzaga set to join PAC-12
Wausau drop box replaced
Tulsa Race Massacre probe
Court reinstates Indiana suit
DOJ report on GA prisons
Top Adams aide resigns
TX fraud probe shut down
GA abortion ban blocked
US sanctions settler group
US job openings rebound
Feedback